# Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials.

> PubMed lists PMID 34866291 in Diabetes, obesity & metabolism as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-12-19 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-34866291-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-07-22
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-34866291-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-34866291-dulaglutide-v1.json
- Content SHA-256: `e98d455d2a71676ff46cb0f56b1a1ba1ebf82b3d8ffba216cd76251e1c3f0115`

## Claims and source pins

### Headline

Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials. ([`pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b`](#source-pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b))

### Summary

PubMed lists PMID 34866291 in Diabetes, obesity & metabolism as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-12-19 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b`](#source-pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b))

### Paragraph 1

PubMed lists PMID 34866291 in Diabetes, obesity & metabolism as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-12-19 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b`](#source-pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b`](#source-pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b))

## Sources

<a id="source-pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b"></a>
- **Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials. · retained source version 1:2022-07-22:current:7db9b1636c0bdfea988695e73f8b8cd10f53e725e0626e5fd1e7d100c47688f4** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/34866291/) (`pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-34866291-dulaglutide-v1.json SHA-256: e98d455d2a71676ff46cb0f56b1a1ba1ebf82b3d8ffba216cd76251e1c3f0115.